Emami and colleagues, the MYH9 gene is emerging as a central player in both cancer biology and inherited genetic conditions, offering fresh perspectives on precision medicine and targeted therapeutics. MYH9 Gene Structure and Core Cellular Functions The MYH9 gene dictates the production of non-muscle myosin IIA, known structurally and functionally as NMIIA. Did you know? … Read more
Researchers at the Memorial Sloan Kettering Cancer Center have identified a single protein called ZFP36L2 that acts as a molecular switch linking the gut’s damage-sensing system to cellular identity shifts, according to a study published August 5 in Nature. According to physician-scientist Karuna Ganesh, senior author of the study, the protein controls how cells detect … Read more
Lactylation-driven metabolic reprogramming acts as a central driver of therapeutic resistance in cancer, according to recent findings published in the journal Genes & Diseases by researchers Wanghao Zhang, Guanglong Huang, Woheng Tang, Jiaxian Li, Jingxian Chen, Yaojiang Feng, Kaichen Li, Can Pan, Shunshen Li, Huayang Zhang, Rongxu Ye, Hao Long, and Guo-zhong Yi. This cellular … Read more
Researchers at The University of Texas at Austin have developed an experimental drug that tricks aggressive cancer cells into consuming more sugar than usual while simultaneously blocking their backup fat metabolism. According to a study published in Nature Chemical Biology, the compound successfully treated an aggressive form of melanoma in mice by attacking both cellular … Read more
Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by high pressure within the skull without a tumor or other identifiable cause. Affecting 1 to 20 people per 100,000—most often women of childbearing age—the condition causes narrowing of the venous sinuses and impaired brain fluid circulation. Recent research published in Nature Neuroscience by the Paris … Read more
Patient-derived tumor organoids are emerging as high-fidelity preclinical models for precision oncology, offering a way to test cancer treatments on three-dimensional cell clusters that mirror a patient’s specific disease. Recent research led by investigators at Weill Cornell Medicine demonstrates that these “avatars” can reliably predict treatment sensitivity, potentially expanding the pool of patients eligible for … Read more
Researchers at the University of Illinois Chicago have identified a molecular switch, the ion channel protein KCNMB1, that regulates cancer cell stiffness. By activating this pathway, scientists can make metastatic cells more rigid, rendering them vulnerable to destruction by the immune system, according to a study published in the journal Developmental Cell. The Physics of … Read more
Senescent cells—damaged cells that stop dividing but remain metabolically active—accumulate lipid droplets as a hallmark of their aging state, according to a study published July 1, 2026, in the journal Aging. Researchers led by Noa Rachmian-Cooper and Valery Krizhanovsky at the Weizmann Institute of Science found that these lipid deposits are linked to chronic inflammation … Read more
Orthonairoviruses, a family of tick-borne pathogens, can bypass human immune defenses using specialized proteins called ovarian tumor domain proteases (OTUs), according to a study led by University of California, Riverside (UCR). This mechanism allows viruses like the Crimean-Congo hemorrhagic fever virus to suppress the body’s ability to detect and fight infection, increasing pandemic risk. How … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more